Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/28/2003CA2471421A1 Rna interference mediated inhibition of protein typrosine phosphatase-1b (ptp-1b) gene expression using short interfering nucleic acid (sina)
08/28/2003CA2471410A1 Purifying process of soluble proteins of the l. obliqua bristles through prothrombin activation; process for a partial determination of the amino acids sequence of the prothrombinactivator; process for determining the prothrombin activation of fraction ii, n-terminal and internal fragments sequences
08/28/2003CA2463595A1 Rna interference mediated inhibition of bcl2 gene expression using short interfering nucleic acid (sina)
08/28/2003CA2460055A1 Insulin and igf-1 receptor agonists and antagonists
08/28/2003CA2459793A1 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
08/28/2003CA2459532A1 Rna interference by modified short interfering nucleic acid
08/28/2003CA2456444A1 Rna interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (sina)
08/28/2003CA2455506A1 Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina)
08/27/2003EP1338657A1 Sequences specifcally deleted from Mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
08/27/2003EP1338651A1 Method of screening remedy for diabetes
08/27/2003EP1338649A1 Novel gene overexpressed in heart and skeletal muscle and use tehreof
08/27/2003EP1338648A1 Pharmaceutically acceptable fixed-dried human blood platelets
08/27/2003EP1338609A1 A further KDR receptor and the use thereof
08/27/2003EP1338606A1 Nucleic Acid encoding an HERV-H polypeptide for diagnosing colorectal cancer
08/27/2003EP1338605A1 N-alkylglycine trimeres capable of blocking the response to chemical substances, heat stimuli or mediators of neuronal receptor inflammation and compositions containing said trimeres
08/27/2003EP1338604A1 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres
08/27/2003EP1337648A2 Novel cyclodextrin glucanotransferase (cgtase), obtained from i bacillus agaradherens /i (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase
08/27/2003EP1337647A2 Helicobacter cysteine rich protein a (hcpa) and uses thereof
08/27/2003EP1337642A1 Cytokin-like proteins
08/27/2003EP1337641A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
08/27/2003EP1337640A2 NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379
08/27/2003EP1337639A2 Master bone formation transcription factor: compositions and methods of use
08/27/2003EP1337636A2 Soluble zcytor 11 cytokine receptors
08/27/2003EP1337634A2 Novel polypeptides involved in immune response
08/27/2003EP1337633A2 Anti-angiogenic proteins and fragments and methods of use thereof
08/27/2003EP1337632A2 Differentiated cells suitable for human therapy
08/27/2003EP1337630A2 Modified arginine deiminase
08/27/2003EP1337629A1 Dipeptidyl peptidases
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337559A2 Regulation of human nmda receptor
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337557A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
08/27/2003EP1337556A2 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof
08/27/2003EP1337551A1 Substance p analogs for the treatment of cancer
08/27/2003EP1337550A2 Hepatitis c tripeptide inhibitors
08/27/2003EP1337548A2 Anti-angiogenic polypeptides
08/27/2003EP1337545A2 Antisense modulation of src-1 expression
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP1337504A2 Novel polyamine analog-amino acid conjugates useful as anticancer agents
08/27/2003EP1337283A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
08/27/2003EP1337282A2 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
08/27/2003EP1337278A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP1337275A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
08/27/2003EP1337271A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
08/27/2003EP1337269A2 Association of calpain inhibitors and reactive oxygen species trapping agents
08/27/2003EP1337268A1 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes
08/27/2003EP1337267A1 Use of blood coagulation factor xiii for treating haemophilia a
08/27/2003EP1337266A1 Mineralized collagen-polysaccharide matrix for bone and cartilage repair
08/27/2003EP1337265A1 Methods of treatment comprising administration of substance p
08/27/2003EP1337259A2 Methylenetetrahydrofolate reductase inhibitors and use thereof
08/27/2003EP1337258A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof
08/27/2003EP1337243A2 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
08/27/2003EP1337242A2 Gene delivery formulations and methods for treatment of ischemic conditions
08/27/2003EP1337236A1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
08/27/2003EP1337228A2 Compositions for removing human cerumen
08/27/2003EP1337149A2 Vaccine immunotherapy for immune suppressed patients
08/27/2003EP1252325A4 Compositions and methods for inhibition of hiv-1 infection
08/27/2003EP1237569B1 An additive for an animal feed
08/27/2003EP1183047B1 Pharmaceutical preparation
08/27/2003EP1181046B1 10-formyltetrahydrofolate dehydrogenase as therapeutical agent
08/27/2003EP1157030B1 Echinocandin/carbohydrate complexes
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1073672B1 Antipicornaviral compounds, their preparation and use
08/27/2003EP1061935A4 Proapoptotic peptides, dependence polypeptides and methods of use
08/27/2003EP0942740B1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
08/27/2003EP0909277B1 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
08/27/2003EP0896525B1 Methods of dry powder inhalation
08/27/2003EP0833657B1 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
08/27/2003EP0832186B1 Replacement therapy for dental caries
08/27/2003EP0832132B1 Lymphocyte chemoattractant factor and uses thereof
08/27/2003EP0821693B1 Novel human cytomegalovirus dna sequences
08/27/2003EP0815084B1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
08/27/2003EP0760685B1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
08/27/2003EP0754051B1 Therapeutic agent for disorder of lipid metabolism
08/27/2003EP0750458B1 Terminal complement inhibitor fusion genes and proteins
08/27/2003EP0706566B1 Conotoxins having acetylcholine receptor binding properties
08/27/2003CN1439056A Herpes viruses for immune modulation
08/27/2003CN1439051A DNA sequences encoding dystrophin minigenes and methods of use thereof
08/27/2003CN1439022A Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439020A Biosynthetic oncolytic molecules and uses therefor
08/27/2003CN1439017A Novel compounds
08/27/2003CN1438905A Microneedle to deliver the substance to the dermis
08/27/2003CN1438895A Peptide composition
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438892A Low carbony drate compositions, kits thereof, and methods of use
08/27/2003CN1438882A Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
08/27/2003CN1438881A The Controlled release preparation of insulin and its method
08/27/2003CN1438879A Endoparasiticidal composition for voluntary oral ingestion by animals
08/27/2003CN1438877A Prolonged release micro spheres for injection delivery and preparation method
08/27/2003CN1438858A Biodegradable vehicles and delivery systems of biologically active substances
08/27/2003CN1438322A Method for diagnosis and treatment of hair eipidermal tumor using human's CYLD gene and its coded products
08/27/2003CN1438321A Method for diagnosis and treatment of lentil disease using human's HSF4 gene and its coded products
08/27/2003CN1438315A Beta-lactamase/amino-glucosidic passive zyme interfused gene, its expressed products and composition thereof and use
08/27/2003CN1438238A Type-c hepatitis virus high-variation-zone 1 synthesized peptide and use thereof
08/27/2003CN1438033A Composite medicine for emergency treatment of acute naphthalene poisoning
08/27/2003CN1438032A Compound preparation for dissolving staphyloase and preparation method
08/27/2003CN1438031A Medicine for resisting tuberculosis and preparation method
1 ... 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 ... 3163